To determine the influence of thrombin, which is generated intraperitoneally during peritoneal dialysis, on the synthesis of fibrinolytic system components in human peritoneal mesothelial cells (HMC). ♦ ♦ ♦ ♦ ♦ Methods: Confluently grown HMC, isolated from the omental tissue, were used in the experiments. Conditioned media were obtained by incubating cells with serum-free M199 containing the appropriate concentration of the test compound. Tissue type plasminogen activator (tPA) and plasminogen activator inhibitor type 1 (PAI-1) antigen concentrations were measured by ELISA. Northern blot analysis was conducted for mRNA expression experiments. To test thrombin specificity, we used the thrombin inhibitor hirudin. The protein kinase C (PKC) inhibitor Ro 31-8220 was inserted to examine whether the effect of thrombin depends on PKC activity. ♦ ♦ ♦ ♦ ♦ Results: Thrombin increased PAI-1 antigen in the conditioned media of HMC in a time-and concentrationdependent manner. After 24 hours incubation, PAI-1 levels increased from 350 ± 30 ng/10 5 cells in control conditions to 620 ± 30 ng/10 5 cells in HMC exposed to 5 U/mL thrombin (n = 8, p < 0.05). In contrast, there was no effect of thrombin on tPA antigen levels. An increase of PAI-1 mRNA expression was also observed by Northern blot hybridization. Hirudin (10 U/mL) inhibited the thrombin-induced increase in PAI-1 synthesis. In addition, a complete inhibition of the stimulating effect of thrombin on PAI-1 synthesis was obtained by blocking PKC activity with Ro 31-8220 (3 µ µ µ µ µmol/L). ♦ ♦ ♦ ♦ ♦ Conclusions: Thrombin increases PAI-1 synthesis in HMC via a PKC-dependent mechanism. Thereby the synthesis of tPA is not affected. Thus, thrombin may not only promote fibrin formation in the peritoneal cavity, but may also inhibit fibrin degradation by release of free PAI-1 from HMC.
T hrombin is not only an essential factor in the coagulation pathway, but it also regulates fibrinolysis (1-3) and has a spectrum of effects on different cell types including platelets, endothelial cells, and fibroblasts (4) (5) (6) . Thrombin has been shown to enhance the synthesis of tissue type plasminogen activator (tPA) and its inhibitor, plasminogen activator inhibitor type 1 (PAI-1), in endothelial cells (1) (2) (3) . These cellular effects require the binding of active thrombin to specific cellular membrane receptors. Like many peptides, thrombin activates phospholipase C and thus causes breakdown of phosphatidylinositol into diacylglycerol, an activator of protein kinase C (PKC) (7) .
We recently demonstrated a plasma independent hypercoagulatory state in the peritoneal cavity of continuous ambulatory peritoneal dialysis (CAPD) patients (8, 9) . Permanent activation of the coagulation cascade by hyperosmolar dialysis solutions increases the intraperitoneal generation of thrombin, resulting in fibrin deposition. Consistent with these findings, morphological studies by Dobbie demonstrate that physical and chemical irritations of the peritoneum through CAPD can result in a nonbacterial serositis with peritoneal fibrin exudation (10-12). As we and others have shown, human peritoneal mesothelial cells (HMC) play an important role in maintaining the balance between peritoneal procoagulant and fibrinolytic activity by producing various regulators of coagulation and fibrinolysis, including tissue factor (13) (14) (15) , thrombomodulin (16) , urokinase-type plasminogen activator (uPA) (17) , and tPA and PAI-1 (18, 19) . Depending on the mesothelial
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by guest on February 20, 2013 http://www.pdiconnect.com/ Downloaded from fibrinolytic capacity, fibrin deposits are lysed or become organized with proliferation of fibroblasts and may promote the formation of peritoneal lesions (20, 21) . This problem is evident during episodes of peritonitis, where an imbalance between fibrinforming and fibrin-dissolving activities of the mesothelium can be observed (8, 9) .
Whether intraperitoneally-formed thrombin also directly affects the synthesis of fibrinolytic system components in HMC is unknown. In the present study we investigated the effect of thrombin on the synthesis of tPA and PAI-1. We report that thrombin stimulates the production of PAI-1 in HMC by a PKC-dependent mechanism.
MATERIALS AND METHODS

MATERIALS
Medium M199 and newborn calf serum were obtained from Gibco-BRL (Eggenstein, Germany), tissue culture plates were from Costar (Cambridge, MA, U.S.A.). Human serum was prepared from freshly collected blood of healthy donors and stored at -20°C. Fibronectin from human serum and trypsin were purchased from Boehringer (Mannheim, Germany). Collagenase type II was from Worthington (Freehold, NY, U.S.A.). Thrombin and r-hirudin were obtained from Behring (Marburg, Germany). The PKC inhibitor Ro 31-8220 was a generous gift from Dr. G. Lawton (Hoffman-La Roche, Welwyn Garden City, U.K.) (22) . Monoclonal antibodies against cytokeratins 8 and 18 and against vimentin were a gift from Dr. G. van Muijen (University of Nijmegen, The Netherlands). Hybond-N filters, Hyperfilm MP, [α 32 P] dCTP (3 µCi/µmol) were obtained from Amersham (Buckinghamshire, U.K.).
CELL CULTURE EXPERIMENTS
Human peritoneal mesothelial cells were isolated from the omental tissue of consenting patients undergoing elective surgery, as described previously (18) . Cells were grown in fibronectin-coated dishes in M199 medium supplemented with 25 mmol/L HEPES (pH 7.3), 2 mmol/L glutamine, 10% (v/v) human serum, 10% (v/v) newborn calf serum (heatinactivated), penicillin (100 IU/mL), and streptomycin (100 µg/mL) at 37°C under 5% CO 2 /95% air atmosphere. The medium was replaced every 2 -3 days. Subcultures were obtained by trypsin/EDTA treatment at a split ratio of 1:3. The cells were pure mesothelial cells as assessed by their uniform cobblestone appearance at confluence, by the absence of von Willebrand factor, and by the uniform positive staining for cytokeratins 8 and 18 and for vimentin (18) . In addition, incubation of cells with doses of tested compounds did not have any significant effect on cell viability as tested by vital cell staining with acridine orange and ethidium bromide, where living cells show green and dead cells show red fluorescence when analyzed by fluorescence microscopy (cell viability exceeded 95%). For the experiments, confluent cultures were used at the second or third passage, and cells were always refed 24 hours before the experiment with M199 supplemented with 2% human serum. Conditioned media were obtained by incubating cells in 2 cm 2 dishes at 37°C with 0.5 mL serum-free M199 containing the appropriate concentration of the test compound or stock solvent. Conditioned media were centrifuged 5 minutes to remove cells and cellular debris, and samples were frozen at -20°C until use.
All experiments were done with cells from 5 to 8 individual donors and were measured in quadruplicate.
ASSAYS
Assay of tPA antigen was performed with the ELISA Coaliza tPA from Chromogenix (Mölndal, Sweden). In this assay, free tPA and tPA/PAI-1 complexes are detected with equal efficiency. PAI-1 antigen was measured by ELISA (Coaliza PAI-1) obtained from Chromogenix.
RNA ISOLATION AND NORTHERN BLOT
Total RNA was extracted from cells as described by Chomczynski and Sacchi (23) . RNA samples were dissolved in water. The RNA concentration in each sample was determined spectrophotometrically. Equal amounts of RNA from different dishes were analyzed for their PAI-1 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA content by Northern blot hybridization. With Northern blotting, RNA samples were subjected to gel electrophoresis in formaldehyde-agarose gels. After electrophoresis, RNA was transferred to Hybond-N according to the instructions of the manufacturer. Hybridization was usually performed at 63°C with 1 ng/mL of probe labeled by random prime labeling (Megaprime, Amersham, Freiburg, Germany) to approximately 2 × 10 8 cpm/µg DNA. The membranes were subsequently exposed to Amersham Hyperfilm-MP with an intensifying screen at -80°C.
cDNA PROBES
The following cDNA fragments were used as probes in the hybridization experiments: a 2.5-kb EcoRI fragment of human PAI-1 cDNA of the 3.1-kb transcript (24) , and a 1.2-kb PstI fragment of a rat GAPDH cDNA provided by Dr. R. Offringa (University of Leiden, The Netherlands), which is commonly used as an internal standard probe (25) .
STATISTICAL ANALYSIS
Data are given as mean ±SEM. Statistical analysis was performed using the Wilcoxon matched-pairs signed rank test for nonparametric data; a p value less than 0.05 was considered to indicate statistically significant differences.
RESULTS
EFFECT OF THROMBIN ON THE SYNTHESIS OF tPA AND PAI-1 IN HMC
Confluent HMC were incubated with various concentrations of thrombin (0.1 -5 U/mL) over 24 hours. As shown in Figure 1 , addition of thrombin resulted in a dose-dependent increase in PAI-1 antigen levels in the cell supernatant, being statistically significant at a concentration of 1 U/mL (p < 0.05). PAI-1 antigen was increased almost twofold after a 24-hour incubation in the presence of 5 U/mL thrombin, compared to nonstimulated conditions (620 ± 30 ng/ 10 5 cells vs 350 ± 30 ng/10 5 cells, n = 8). Thrombin (5 U/mL) stimulated PAI-1 synthesis also in a timedependent manner and 24 hours' incubation was required to observe a significant increase in PAI-1 antigen (Figure 2 ). The increase in PAI-1 antigen in HMC after addition of thrombin was paralleled by comparable changes in PAI-1 mRNA expression, indicating that the effect of thrombin is at the level of gene transcription or mRNA stability (Figure 3) .
In contrast to PAI-1 antigen, the production of tPA in HMC was not affected by any of the thrombin concentrations used, as shown in Figure 4 .
MECHANISMS OF ACTION OF THROMBIN ON HMC
The specificity of the thrombin effect was tested by addition of hirudin, a natural inhibitor of thrombin, which blocks both proteolytic and membrane receptor binding functions of thrombin. When the HMC treated with thrombin (5 U/mL) were simultaneously incubated with hirudin (10 U/mL), a significant inhibition of the increase in PAI-1 synthesis was obtained ( Figure 5 ).
Ro 31-8220, a specific inhibitor of PKC, was used to investigate which intracellular pathway was stimulated by thrombin. As shown in Figure 5 , Ro 31-8220 used in a concentration-dependent manner (1 -3 µmol/L) quenched the thrombin-induced increase in PAI-1 synthesis completely. These findings indicate that thrombin upregulates the expression of PAI-1 in HMC via a PKC-dependent mechanism.
DISCUSSION
This study was initiated to determine possible effects of thrombin on the synthesis of fibrinolytic system components in HMC. We have previously shown that HMC in culture can produce tPA and PAI-1, and that inflammatory mediators decrease the fibrinolytic potential by increasing PAI-1 and decreasing tPA synthesis (13) . These results suggest that HMC play a crucial role in the pathophysiology of peritoneal fibrin deposition during peritoneal dialysis, which is commonly associated with submesothelial peritoneal fibrosis (12) .
In our present study we report that thrombin increases the synthesis of PAI-1 in HMC. We demonstrated a concentration-dependent increase in PAI-1 antigen in the presence of thrombin, which was paralleled by comparable changes in mRNA expression. These results suggest that thrombin stimulates PAI-1 gene transcription in HMC.
PAI-1 plays a pivotal role in fibrinolytic and fibrogenetic processes by inhibiting plasminogen activators (uPA, tPA) and, consequently, a cascade of events including generation of plasmin, plasmin-induced fibrin degradation, and activation of the proenzymatic forms of matrix metalloproteinases (26) . Therefore, an imbalance between the mesothelial production of tPA and PAI-1 may account for the peritoneal fibrotic thickening that occurs after long-term peritoneal dialysis (11, 12, 27) .
In contrast to our observation that tPA synthesis was not increased by thrombin in HMC, enhanced synthesis of tPA and PAI-1 by human endothelial cells has been reported (1) (2) (3) . Because HMC and endothelial cells respond differently to thrombin with respect to tPA synthesis, it is reasonable to suppose that different mechanisms are involved in the regulation of tPA synthesis in the two cell types. This hypothesis is supported by our previous observation that retinoids and phorbolester, which are known as potent stimulators of tPA synthesis in human vein endothelial cells, could not increase tPA synthesis in HMC (13) . The effect of thrombin on PAI-1 synthesis in HMC is probably mediated by an interaction with specific thrombin receptors. Although we did not directly demonstrate their presence on HMC, our findings are consistent with properties of thrombin receptors: hirudin, which blocks both catalytic activity and binding of thrombin to its receptor, inhibited the thrombinmediated increase in PAI-1 synthesis. In addition, the increase of PAI-1 synthesis was also blocked by the PKC inhibitor Ro 31-8220, indicating that activation of PKC was required for the effect of thrombin on PAI-1 synthesis. These findings support the suggestion that thrombin activates phospholipase C via interaction with the thrombin receptor, which then generates diacylglycerol, an activator of PKC (7) . In accordance with our results that tPA synthesis was not increased in the presence of thrombin, it has been reported that activation of PKC with the phorbolester PMA induces the synthesis of PAI-1 in HMC, without affecting tPA expression (13) .
In summary, our results demonstrate that thrombin increases PAI-1 synthesis in HMC via a PKCdependent mechanism. Thereby the synthesis of tPA is not affected. Thus, thrombin may not only promote fibrin formation in the peritoneal cavity during peritoneal dialysis, but may also inhibit fibrin degradation by release of free PAI-1 from HMC. Since the imbalance of intracavity fibrin formation and removal is important in the pathogenesis of peritoneal lesions in peritoneal dialysis, preventive strategies should include the application of heparin or hirudin in patients with peritonitis.
